Identification of candidate responders for anti-PD-L1/PD-1 immunotherapy, Rova-T therapy, or EZH2 inhibitory therapy in small-cell lung cancer.

Autor: Saito, Motonobu1,2 mosaitoh@ncc.go.jp, Saito, Katsuharu2, Shiraishi, Kouya1, Maeda, Daichi3, Suzuki, Hiroyuki4, Minamiya, Yoshihiro5, Kono, Koji2, Kohno, Takashi1, Goto, Akiteru3
Zdroj: Molecular & Clinical Oncology. 2018, Vol. 8 Issue 2, p310-314. 5p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje